$Labcorp Holdings (LH.US)$
Can a Simple Blood Draw Replace Tumor Biopsies? Labcorp's New Cancer Test Changes the Game

$IQVIA Holdings (IQV.US)$   wondering why no movement for this stock despite good target price from institutions ?

$Charles River (CRL.US)$ It’s cheap, but no sizable upside without material improvement of the earnings. 140s might be in the cards. Go against the trend is a dangerous thing. Those sitting on a loss have to cut loss given the extreme resistance above. Only improvement of the earnings can save this stock. They also seem to be losing some clients to competitors.

$IQVIA Holdings (IQV.US)$ Will be over 220 by the end of the month

$Charles River (CRL.US)$ In this almost everything rally market with stocks doubling easily, biomedical research companies have found growth is extremely hard to come by, and P/E has been stuck going nowhere.

Morning Movers
Gapping up
$Meta Platforms (META.US)$ stock rose 8.9% following stronger-than-expected second-quarter earnings and a positive future outlook.
$ConocoPhillips (COP.US)$ stock increased by 0.8% after reporting a second-quarter profit that surpassed estimates, aided by higher output and oil prices.
$Ferrari (RACE.US)$ stock climbed 3.3% as the company raised its full-year revenue and core earnings forecasts, having ex...

$Quest Diagnostics (DGX.US)$ PathAI +  Invigorate + stable finance + qualified management team + decent PE.
Will it dominate pathology and cancer diagnosis with AI in the future? Worth noting.